Thursday, October 31, 2019

Cadila Healthcare gets EIR from USFDA for Baddi facility

Cadila Healthcare gets EIR from USFDA for Baddi facility "The company#39;s formulations manufacturing facility located at Baddi, India, has received an EIR. The United States Food and Drug Administration (USFDA) had conducted an inspection at the facility from July 15 to 19, 2019," Cadila Healthcare said in a filing to BSE.

from Moneycontrol Business News https://ift.tt/2N1stW1
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Tariffs a temporary storm, structural reforms key for India: Arvind Sanger

Arvind Sanger of Geosphere Capital Management suggests a trade deal with the U.S. would benefit India by reducing market uncertainty and pro...